Skip to main content
European Commission logo print header

Validation of a new drug target in non-alcoholic steatohepatitis

Ziel

This research focuses on the increasing prevalence of metabolic liver disease, specifically non-alcoholic steatohepatitis (NASH), which is driven by obesity, diabetes, and its related causal connections. NASH is a significant medical challenge with no approved treatments, causing a substantial economic burden. The project aims to investigate the role of oxidative stress in NASH development and progression. By targeting the MAP kinases p38 and JNK, which drive the inflammatory and fibrotic aspects of NASH, our research could lead to new treatment approaches.

Schlüsselbegriffe

Programm/Programme

æ

Koordinator

KOBENHAVNS UNIVERSITET
Netto-EU-Beitrag
€ 150 000,00
Adresse
Norregade 10
1165 Kobenhavn
Dänemark

Auf der Karte ansehen

Region
Danmark Hovedstaden Byen København
Aktivitätstyp
Higher or Secondary Education Establishments
Links
EU-Beitrag
Keine Daten